Table 2.
Outcome comparison between groups.
| Outcomes | Tertile 1 | Tertile 2 | Tertile 3 | p-Values |
|---|---|---|---|---|
| (<1.36) | (1.36–1.96) | (≥1.96) | ||
| Total patients | ||||
| ACM (n, %) | 33 (2.9) | 39 (3.3) | 57 (4.9) | 0.026 |
| CM (n, %) | 18 (1.6) | 28 (2.4) | 36 (3.1) | 0.054 |
| MACE (n, %) | 132 (11.6) | 123 (10.5) | 135 (11.7) | 0.636 |
| MACCE (n, %) | 164 (14.4) | 168 (14.4) | 177 (15.3) | 0.782 |
| ACS patients | ||||
| ACM (n, %) | 26 (3.0) | 30 (3.3) | 40 (4.5) | 0.048 |
| CM (n, %) | 14 (1.6) | 23 (2.6) | 23 (2.6) | 0.300 |
| MACE (n, %) | 102 (11.8) | 92 (10.2) | 99 (11.2) | 0.546 |
| MACCE (n, %) | 124 (14.4) | 125 (13.9) | 135 (15.3) | 0.679 |
| CCS patients | ||||
| ACM (n, %) | 7 (2.4) | 9 (3.3) | 18 (6.4) | 0.017 |
| CM (n, %) | 4 (1.4) | 5 (1.9) | 13 (4.6) | 0.036 |
| MACE (n, %) | 34 (11.8) | 31 (11.5) | 37 (13.1) | 0.831 |
| MACCE (n, %) | 45 (15.7) | 43 (16.0) | 43 (15.2) | 0.972 |
ACM, all-cause mortality; CM, cardiac mortality; MACE, major adverse cardiovascular events; MACCE, major adverse cardiovascular and cerebrovascular events; ACS, acute coronary syndrome; CCS, chronic coronary syndrome.